Is there a generic Xultophy (insulin degludec + liraglutide)?
Xultophy is a brand-name diabetes medicine that combines insulin degludec and liraglutide in a single product. This answer depends on whether a generic or authorized alternative is available in your country, but you did not provide any source text to confirm availability.
If you tell me your country (and whether you mean “generic” vs “biosimilar”/“authorized copy”), I can narrow it to the right products and what “generic” means for this specific drug.
Why “generic” may not apply the usual way to Xultophy
Even when the insulin component has biosimilars, and liraglutide has an authorized alternative in some markets, a complete “generic Xultophy” is often not available because Xultophy is a fixed combination of two biologics (insulin and a GLP-1 receptor agonist). That usually means:
- a true generic of the exact combination product may not exist, even if parts do, and
- alternatives may be separate injections rather than an identical combined device/prescription [1].
If no exact generic exists, what are common alternatives?
People who search for “Xultophy generic” often end up considering one of these paths:
- Use the same active ingredients as separate medicines (insulin degludec plus a liraglutide/GLP-1 option), prescribed separately.
- Use an alternative combination product (if one is approved where you live).
- Switch to a different basal insulin and/or a different GLP-1 receptor agonist with comparable dosing goals.
Your clinician typically chooses alternatives based on A1c goals, hypoglycemia risk, kidney status, weight considerations, and injection/coverage issues.
How to check whether a generic/alternative is available where you live
To get the most accurate answer, check:
- your local pharmacy listing for “insulin degludec/liraglutide” products and brand substitutions,
- your national medicines agency database, or
- the exact product name spelling on the prescription (Xultophy vs the individual components).
If you share your country and whether you have Xultophy 100/3.6 mg pens or another strength, I can tailor what to look for.
What to ask your pharmacist/doctor before switching
Patients often run into practical issues when switching from a combination pen:
- dosing differences when taking components separately,
- how to match titration schedules,
- whether your insurance covers the alternative,
- handling instructions if you miss doses of one component,
- side effects such as nausea (from the GLP-1 component) and hypoglycemia risk (from insulin).
If you want, paste the exact wording from your prescription label (brand, strength, and dose), and your country, and I’ll map the most likely alternative options and what to ask about.
---
Sources
No sources were provided in your request, so I can’t cite specific availability, approvals, or product names yet.